Karolin Guldevall (K Guldevall)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 2

Top Topics

Top Venues

Cancer immunology, immunotherapy : CII

Journal of immunology (Baltimore, Md. : 1950)

Royal Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Royal Institute of Technology Dec 01 2008 - Mar 25 2014

Sweden

PHD :: Applied Physics

Publications

Jolien M R Van der Meer, Ralph J A Maas, Karolin Guldevall, K Klarenaar, P K J D de Jonge, J S Hoogstad-van Evert, Anniek B van der Waart, J Cany, J T Safrit, J H Lee, E Wagena, Peter Friedl, Björn Önfelt, Leon F A G Massuger, Nicolaas P M Schaap, Joop H Jansen, Willemijn Hobo, Harry Dolstra
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells. Cancer immunology, immunotherapy : CII 70 (5) (2020)
Katherine Walwyn-Brown, Karolin Guldevall, Mezida Saeed, Daniela Pende, Björn Önfelt, Andrew S MacDonald, Daniel M Davis
Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. Journal of immunology (Baltimore, Md. : 1950) 201 (7) (2018)